Sign in

CIK 0001357459

  • Non-accelerated filer
  • Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522007292
Phone
+1 858-704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Open-market buys, last 90 days
$28,800
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Williams Donald Allen +$29K Director 1 filing

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +20,392 20,392
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +15,002 15,002
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +12,294 12,294
2021-04-27 Hallam Thomas Chief Executive Officer Grant or award · Stock Option (Right to Buy) +27,190 27,190
2021-04-27 Finley John David Chief Financial Officer Grant or award +2,396 2,396
2021-04-27 Finley John David Chief Financial Officer Grant or award +26,322 26,322
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +10,418 10,418
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +9,516 9,516
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +52,068 52,068
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +14,708 14,708
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +5,662 5,662
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +19,033 19,033
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +9,702 9,702
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +7,952 7,952
2021-04-27 Finley John David Chief Financial Officer Grant or award · Stock Option (Right to Buy) +2,595 2,595
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +95 95
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +51 51
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +49 49
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +339 339
2021-04-27 Finley John David Chief Financial Officer Grant or award · Warrant (Right to Buy) +503 503

Page 15 of 21 · 409 trades